Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
about
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyImplantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerationsOptimal programming management of ventricular tachycardia storm in ICD patientsValue of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment?The subcutaneous ICD-current evidence and challengesImpact of the introduction of a standardised ICD programming protocol: real-world data from a single centre.Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trialMorphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study.[Inappropriate ICD therapies: All problems solved with MADIT-RIT?].Evaluation of defibrillation safety and shock reduction in implantable cardioverter-defibrillator patients with increased time to detection: A randomized SANKS study.Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis.The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance.Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative studyFuture Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older PatientsInappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis.2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Late gadolinium enhancement among survivors of sudden cardiac arrestTachyarrhythmia Cycle Length in Appropriate versus Inappropriate Defibrillator Shocks in Brugada Syndrome, Early Repolarization Syndrome, or Idiopathic Ventricular Fibrillation.Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-AnalysisThe wizard behind the curtain: programmers as providersMeasuring quality in electrophysiology.Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea.Deactivation of implantable cardioverter-defibrillators at end of life.Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators.ICD programming.ICD programming to reduce shocks and improve outcomes.Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.Programming implantable cardioverter/defibrillators and outcomes.Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.Management of ventricular arrhythmias in structural heart disease.European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator.Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry.Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.Optimal tachycardia programming in ICDs : Recommendations in the post-MADIT-RIT era.
P2860
Q26796261-1A04C18E-1B7A-4992-AA4C-D0F0F13A2003Q26852920-3711BAD7-9551-41B6-AF0A-A6B674084A40Q26853104-E7C338BB-83F4-42D9-A1ED-701D5B0EBD18Q28067809-250B7A97-EB40-4FAC-B171-AD8E37CF664FQ28081541-E234BAEF-0800-43E3-8185-56E13BF3D0A6Q28081629-946ABF8C-A9E9-42E4-9893-ED7B7CB554F5Q31105448-CD188E35-C93A-44C5-84AB-5F1F807EBC03Q31119225-E2652FE2-44D6-4B13-98A1-85669451AAACQ33163249-EC02E9D4-E803-410F-B7E0-C03CE2F19B8EQ33165644-877C11ED-F4FF-4C27-BC63-310A4993212AQ33166181-A553E6C5-E161-4863-8F1C-E01DB97C2815Q33166757-54A7E54E-2565-4673-B303-6AE9BD775B74Q33167254-83EEC9BE-1D06-4D32-A09C-4289654A1E21Q35095123-08D12561-9E0D-4677-A4A8-81B6E3E8DFECQ35539464-D6765412-101C-4368-A6AD-1655B7FD8C15Q35906753-397AE462-8249-4FE1-946E-ADDB86AA2BA3Q36258431-687EB809-FC75-4EBF-ACF1-6115322DE474Q36322305-8F37E8A3-98C7-4D45-A6CB-DE0739EB6FB1Q36594611-0C0241BF-F825-4F1F-92BF-67721FD24080Q36672304-556FF5D0-99D7-42F1-B367-1221869D8148Q36723479-BB501B32-A94B-4BB3-BE9D-A6939AEC2EADQ36836290-A412FC27-7A37-4998-8F77-9227AF02D371Q37154225-E0189FA8-3556-4AAE-A07D-9891414EE455Q37441769-556F4529-2B46-40BE-BBAE-344BED8111F0Q37723281-29F5F0E0-28B0-46EC-8641-D43852673A72Q38158220-93F69FC2-25C9-41A2-ADF6-EB5C8A316D85Q38167290-16B8EC2E-4594-485B-9F2E-173FF54AE24EQ38191070-F3E596BC-4DCB-46C3-8B14-FBB34E43B42BQ38211070-2CAF0B26-4875-43CD-90B4-9637B065ACDCQ38244795-0E86C19D-3898-409E-A02F-433772483028Q38259509-989CB0D4-44BE-46F2-96EB-EE899CD5E323Q38364204-DDC6D556-6714-481C-8C90-C394AC434CB5Q38411076-EB295BD7-2ECE-443B-B85D-B7AA19211DB7Q38477990-5D07582C-691A-45DC-8857-759B553D31BAQ38571627-896A7D09-8528-499F-BB3F-8D20F292A3C5Q38574449-4E5FE6FF-14D0-466A-B6BC-682143E5B248Q38679816-64742231-3C09-4DE6-82B3-D5265BA88860Q38724112-6FB35359-1BAC-492F-BCF0-13DFD5FC8474Q38903885-77796DFE-8292-4052-A15C-CCC9C9F7CB5AQ38953682-92D73DF4-5E9C-4D3C-9899-E631DD86F2DF
P2860
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effect of long-detection inter ...... III randomized clinical trial.
@ast
Effect of long-detection inter ...... III randomized clinical trial.
@en
type
label
Effect of long-detection inter ...... III randomized clinical trial.
@ast
Effect of long-detection inter ...... III randomized clinical trial.
@en
prefLabel
Effect of long-detection inter ...... III randomized clinical trial.
@ast
Effect of long-detection inter ...... III randomized clinical trial.
@en
P2093
P356
P1476
Effect of long-detection inter ...... III randomized clinical trial.
@en
P2093
Ahmad Hersi
Angel Arenal
Axel Kloppe
Elisabetta Santi
José Bautista Martìnez Ferrer
Laura Manotta
Marcin Gulaj
Maurits C E F Wijfels
Maurizio Gasparini
Maurizio Lunati
P304
P356
10.1001/JAMA.2013.4598
P407
P577
2013-05-01T00:00:00Z